Case Report: Could Myocarditis + Shortness of Breath = EGPA?

Ambreesh Chawla, MD, is a first-year rheumatology fellow at the University of Central Florida College of Medicine, Orlando, Fla. His clinical interests include vasculitis and connective tissue disease-related ILD.

Ashwini Komarla, MD, is a rheumatologist at the Orlando VA Medical Center. She is an assistant program director for the UCF/VA Rheumatology Fellowship Program.

Sujatha Vuyyuru, MD, is the department chief of rheumatology at the Orlando VA Medical Center. She is the program director for the UCF/VA Rheumatology Fellowship Program.

References

1. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol. 1951 Mar-Apr;27(2):277–301.
2. Keough KA, Specks U. Churg-Strauss syndrome. Semin Respir Crit Care Med. 2006 Apr;27(2):148–157.
3. Mayo Clinic. Churg-Strauss syndrome—Symptoms.
4. Churg A. Pulmonary angiitis and granulomatosis revisited. Hum Pathol. 1983 Oct;14(10):868–883.
5. Conron M, Beynon HL. Churg-Strauss syndrome. Thorax. 2000 Oct;55(10):870–877.
6. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990 Aug;33(8):10941–100.
7. Giofreddi A, Maritati F, Olivia E, et al. Eosinophilic granulomatosis with polyangiitis: An overview. Front Immunol. 2014 Nov 3;5:549.
8. Wechsler ME, Akuthota P, Jayne D, et al. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis. N Engl J Med. 2017 May 18;376(20):1921–1932.
9. Cottin V, Bel E, Bottero P, et al. Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Autoimmun Rev. 2017 Jan;16(1):1–9.
10. Sinico RA, Di Toma L, Maggiore U, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg‐Strauss syndrome. Arthritis Rheum. 2005 Sep;52(9):2926–2935.
11. Moosig F, Bremer JP, Hellmich B, et al. A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): Monocentric experiences in 150 patients. Ann Rheum Dis. 2013 Jun;72(6):1011–1017.
12. Guillevin L, Cohen P, Gayraud M, et al. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore). 1999 Jan;78(1):26–37.
13. Choi YH, Im JG, Han BK, et al. Thoracic manifestations of Churg-Strauss syndrome: Radiological and clinical findings. Chest. 2000 Jan;117(1):117–124.
14. Neumann T, Manger B, Schmid M, et al. Cardiac involvement in Churg-Strauss syndrome: Impact of endomyocarditis. Medicine (Baltimore). 2009 Jul;88(4):236–243.
15. Corradi D, Maestri R, Facchetti F. Postpartum Churg-Strauss syndrome with severe cardiac involvement: Description of a case and review of the literature. Clin Rheumatol. 2009 Jun;28(6):739–743.
16. Groh M, Pagnoux C, Baldini C, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med. 2015 Sep;26(7):545–553.
17. Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore). 1996 Jan;75(1):17–28.
18. McBrien CN, Menzies-Gow A. Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis. Drugs Today (Barc). 2018 Feb;54(2):93–101.